Recurrent Symptomatic Amoebiasis in a Rural Kenyan Hospital - A Case Report




Amoebiasis, Entamoeba Histolytica, Feco-Oral Transmission, Metronidazole, Invasive Amoebiasis, Recurrent Amoebiasis, Kenya


Entamoeba histolytica is an extraintestinal protozoa that is feco-orally transmitted and exists as cysts or trophozoites, which may cause either asymptomatic infection or invasive intestinal and extraintestinal disease, respectively. Most infections (amoebiasis) are found in communities with poor environmental sanitation and unhygienic water and food handling practices. Recurrent symptomatic intestinal amoebiasis is associated with significant personal and public health cost implications and warrants a deliberate and thorough search for a source of the feco-oral transmission. In this study, we present a case of a woman with recurrent symptomatic amoebiasis to underscore the importance of a detailed social history in establishing source control in the case management of amoebiasis.


Download data is not yet available.


Atabati, H., Kassiri, H., Shamloo, E., Akbari, M., Atamaleki, A., Sahlabadi, F., Linh, N. T. T., Rostami, A., Fakhri, Y., & Khaneghah, A. M. (2020). The association between the lack of safe drinking water and sanitation facilities with intestinal Entamoeba spp infection risk: A systematic review and meta-analysis. PLoS One, 15(11), e0237102.

Carrero, J. C., Reyes-López, M., Serrano-Luna, J., Shibayama, M., Unzueta, J., León-Sicairos, N., & de la Garza, M. (2020). Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. Int J Med Microbiol, 310(1), 151358.

Kantor, M., Abrantes, A., Estevez, A., Schiller, A., Torrent, J., Gascon, J., Hernandez, R., & Ochner, C. (2018). Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development. Can J Gastroenterol Hepatol, 2018, 4601420.

Marie, C., & Petri, W. A., Jr. (2013). Amoebic dysentery. BMJ Clin Evid, 2013.

Morán, P., Serrano-Vázquez, A., Rojas-Velázquez, L., González, E., Pérez-Juárez, H., Hernández, E. G., Padilla, M. L. A., Zaragoza, M. E., Portillo-Bobadilla, T., Ramiro, M., & Ximénez, C. (2023). Amoebiasis: Advances in Diagnosis, Treatment, Immunology Features and the Interaction with the Intestinal Ecosystem. Int J Mol Sci, 24(14).

Ngowi, H. A. (2020). Prevalence and pattern of waterborne parasitic infections in eastern Africa: A systematic scoping review. Food Waterborne Parasitol, 20, e00089.

Petri, W. A., & Haque, R. (2013). Entamoeba histolytica brain abscess. Handb Clin Neurol, 114, 147-152.

Quach, J., St-Pierre, J., & Chadee, K. (2014). The future for vaccine development against Entamoeba histolytica. Hum Vaccin Immunother, 10(6), 1514-1521.

Saidin, S., Othman, N., & Noordin, R. (2019). Update on laboratory diagnosis of amoebiasis. Eur J Clin Microbiol Infect Dis, 38(1), 15-38.

Shamsuzzaman, S. M., & Hashiguchi, Y. (2002). Thoracic amebiasis. Clin Chest Med, 23(2), 479-492.

Singh, R. S., Walia, A. K., Kanwar, J. R., & Kennedy, J. F. (2016). Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin. Int J Biol Macromol, 91, 258-268.

Usuda, D., Tsuge, S., Sakurai, R., Kawai, K., Matsubara, S., Tanaka, R., Suzuki, M., Takano, H., Shimozawa, S., Hotchi, Y., Tokunaga, S., Osugi, I., Katou, R., Ito, S., Mishima, K., Kondo, A., Mizuno, K., Takami, H., Komatsu, T., . . . Sugita, M. (2022). Amebic liver abscess by Entamoeba histolytica. World J Clin Cases, 10(36), 13157-13166.

Ximénez, C., Morán, P., Rojas, L., Valadez, A., Gómez, A., Ramiro, M., Cerritos, R., González, E., Hernández, E., & Oswaldo, P. (2011). Novelties on amoebiasis: a neglected tropical disease. J Glob Infect Dis, 3(2), 166-174.




How to Cite

Onyango, V. C., Gachie, S. M., Mutiso, B., Mutua, D., & Mutuma, N. M. (2023). Recurrent Symptomatic Amoebiasis in a Rural Kenyan Hospital - A Case Report. American Journal of Medical Science and Innovation, 2(2), 171–174.